HS-10542

DRUG2 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

HealthyParoxysmal Nocturnal Hemoglobinuria

Phase 1

HS-10542 Study in Healthy Participants

RecruitingNCT07040046

Jiangsu Hansoh Pharmaceutical Co., Ltd.Healthy

Start: 2025-05-16End: 2026-03-31Target: 100Updated: 2025-06-26

Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria

RecruitingNCT07470762

Jiangsu Hansoh Pharmaceutical Co., Ltd.Paroxysmal Nocturnal Hemoglobinuria

Start: 2026-02-14End: 2029-07-31Target: 50Updated: 2026-04-13